This can lead to delays in diagnosis as sleep apnea in women can be mistaken for anxiety, depression and menopause. As the ...

About 50% of children with Down syndrome experience obstructive sleep apnea. That number is even higher for adults with the ...

Increased risk for all-cause and CVD mortality in OSA may be linked to a severe phenotype marked by objective excessive daytime sleepiness.

Providers who manage GERD or IBD should know how obstructive sleep apnea can influence gastrointestinal disorders.

University of Arizona Health Sciences researchers will take a precision medicine approach to treating obstructive sleep apnea in people with Down syndrome.

Vivos Therapeutics, Inc. has announced the publication of positive results from a multicenter clinical trial on its Daytime-Nighttime Appliance (DNA) for treating obstructive sleep apnea (OSA) in ...

Obstructive sleep apnea affects nearly 1 billion people globally, with the majority undiagnosed and underserved with current treatment options REDWOOD CITY, Calif., June 9, 2025 /PRNewswire/ -- ...

A clash is brewing between doctors and patients when it comes to treatment for sleep apnea in those with obesity, a new study reports.

Potential climate change scenarios could nearly double the global incidence of obstructive sleep apnea (OSA), based on estimates from a new study presented at American Thoracic Society (ATS) 2025 ...

Sleep apnea causes the breathing to repeatedly stop and start during sleep, which can result in low oxygen levels. Symptoms include daytime sleepiness, loud snoring, restless sleep, and more.

Obstructive Sleep Apnea (OSA) remains a widespread yet under-treated condition, affecting millions globally. Traditional treatments such as CPAP therapy, while effective, are often hindered by poor ...

Apnimed’s obstructive sleep apnea drug reduced breathing interruptions in a Phase 3 clinical trial. The once-nightly pill, which is based on research from Brigham and Women’s Hospital ...